You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.


Test Information


Cepheid is expanding its Oncology portfolio to deliver life-changing technology to physicians and their cancer patients globally. We also offer a rapid test that detects the genetic risk for thrombosis.


Xpert® BCR-ABL Ultra

Sensitive and quantitative monitoring of BCR-ABL mRNA in patients with chronic myelogenous leukemia (CML)

Learn More

Xpert® BCR-ABL Ultra p190

Sensitive and quantitative monitoring of BCR-ABL p190 and ABL mRNA in patients with chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL)

Learn More

Xpert® Bladder Cancer Detection

Detection of the presence of bladder cancer in patients with hematuria in 90 minutes 

Learn More

Xpert® Bladder Cancer Monitor

Qualitative monitoring for recurrence in patients previously diagnosed with bladder cancer in 90 minutes

Learn More

Xpert® Breast Cancer STRAT4

Standardized breast cancer ESR1/PGR/ERBB2/MKi67 mRNA biomarker assessment in less than two hours

Learn More

Xpert® FII & FV

30-minute Test for Genetic Risk of Thrombosis

Learn More

CE-IVD. In Vitro Diagnostic Medical Device. Not available in all countries.
Back to Top